# Introduction ne of the leading causes of morbimortality worldwide is coronary artery disease (CAD), which has many risk factors in the pathophysiology of the issue, which is why the forerunning risk factor is diabetes mellitus type 2(DM2) 1 .In patients with DM2, CAD is more likely to be a complex disease characterized by small, diffuse, calcified, multivessel disease and often requires coronary revascularization 2,3 . Many clinical trials 1,2,[4][5][6][7][8] have demonstrated that postoperative myocardial infectious complications in patients with DM2 are associated with the following conditions: blood glucose control, length of stay in the hospital, or in the intensive unit care (ICU), renal failure and previous lung disease 8,9 . The current study evaluates which variables are associated with a significant risk of hospital infection of any nature in patients with DM2. The central hypothesis is that preoperative blood glucose level, and HbA1c on in-hospital outcomes, principally associated with infections after CABG. # II. # Methodology This is a transversal study; we have collected data between 2015 and 2017 from all patients with type 2 diabetes who passed through a Coronary Artery Bypass Grafting. During this period, CABG performed in 43 patients with DM2. This number has reached because of inclusion criteria: 1) patients who would pass through a cardiac surgery, 2) patients diagnosed with DM2, 3) patients under the care of endocrinology staff. And the exclusion criteria were faulting data at the medical records of those patients. Moreover, were collected the following records: gender, age, HbA1c level, time diabetic diagnosed, insulin user (yes or not), time-elapsed in hospital and the ICU, smoking history, pulmonary disease, and infection postoperative. The Ethical Committee in Research approved this study by the BIOCOR hospital. # III. # Statistical Analysis The chi-square test used in categorical variables (for example, presence or absence of lung disease, use of insulin or not, etc.), with the p-value calculated by the person's square. In the univariate analysis, the continuous numerical variables, when in the standard distribution in the course of Gauss, were analyzed by the T-test of independent samples. And, when not parametric, they were analyzed by the Mann Whitney U test. IV. # Results Were collected data from 43 patients with DM2 that passed through a CABG for myocardial revascularization. The average age was 65, an average of 8 years diagnosed with DM2 (standard deviation of 8,8), and from all, only 34,8% used insulin to treat and normalize glucose levels (Table 1). Moreover, were identified an average of glycohemoglobin of 7, 4. Furthermore, 14, 6% of the patients had some type of infectious disease after CABG. Those with infection postoperative had a glycohemoglobin 7, 9 (SD ±1,4), and those without infection had an HbA1c 7,25 (SD ±0,94) and a p-value from 0,039 (graphic1).Adding this was identified that the average of creatinine clearance in those patients with the infectious disease was 59 (SD ±21,3) and 67 (SD ±26) in those without infection, calculated a p-value from 0,039 (table 2). V. # Discussion This study has shown that high levels of Hb1Ac and low levels of creatinine clearance are a predictor of infection disease post CADG. Izadi, et al. (2014) 19 have demonstrated that immunosuppression induced by hyperglycemiaketoacidosis can be considered as the precedent factor in patients with DM2 to infection, principally after CADG 1,5,13,18,19 . Comparatively, our study showed high levels of infection disease postoperative in patients with previous uncontrolled Hb1AC. It is controversial what glycemic parameter used as a predictor of postoperative infection disease after CABG. Some authors defend tight blood glucose control as a decreasing factor of morbidity, mortality, and lower rates of infection after cardiac surgeries, principally associated with blood glucose < 200 mg/dL, and <139mg/dL if in ICU. Others defend a more straight target of blood glucose (81 to 108 mg/dL) 1,7,9,12,24 . Other researchers advocate that patients with HbA1c lower than 7% have a better outcome than patients with poorly controlled diabetes (HbA1c> 7%) 13 , which also demonstrated with our results that those patients with infectious disease had an HbA1c> 7,9. Also, patients with HbA1c lower than 7% had similar outcomes compared to those without diabetes diagnosis 16,18,25 . This can corroborate with Halkos et al. (2008) 16 , demonstrating a significant increase in in-hospital mortality, renal failure, cerebrovascular accident, deep sternal wound infection, and a composite index of infection in those patients with HbA1c levels higher than 7%. So then, preoperative glycosylated hemoglobin emerges as a predictor of mortality and principally infections postoperative after CABG 16 . Another variable as a predictor of postoperative infection is the creatinine clearance (CrCl). As shown by Kassaianet al. (2012) 18 and Halkos et al. (2008) 16 , CrCl, as HbA1c levels, predict infection disease postoperative 7,8,12,26,27 . We have also shown similar results. In all patients with infection after CAGD, the CrCl was lower than 59, with a p-value of 0,039. There are potential limitations in our study that needs to mention. First, it designs retrospective research. Second, this was a single-center experience, and larger multi-center studies should confirm our findings. Third, multivariable analysis was not made, so independent associations cannot be summarized from this study. # VI. # Conclusion In summary, high levels of Hb1Ac are a predictor of infection disease post CADG. Thereby, patients with coronaropathy must be the glucose levels, and mainly HbA1c levels, evaluated before cardiac surgery. Moreover, creatinine clearance should also be evaluated to predict poor outcomes postoperative in patients with DM2. These findings demonstrate that it is quite essential a holistic medical evaluation in patients with DM2 before cardiac surgeries, focusing on the glucose levels control, HbA1c, and renal function to obtain a lower risk of postoperative infectious complications. Further researches must be developed to evaluate, prospectively, with a biggersample, a significant association between HbA1c and postoperative infection in patients with DM2 submitted through a CABG. 1VariablesN (%) or median (Quartile 25-75%) or average (SD)Age (years)65 (± 9,3)Female17 (39,6%)Glycohemoglobin (%)7,40 (±1,08)Length of DM2 (years)8 (±8,8)Length of hospital stay until surgery(days)5 (±8,8)Drain time in UCI (days)1Length of stay in UCI (days)2 (±1,5)Creatinine clearance (mL/min)67 (±25,5)Presence of infectious disease after CABG8 (14,6%)Use of insulin before hospitalization15 (34,8%)Smoking3 (7,3%)Pulmonary disease8 (19,5%) 2VariablesAbsence of infectiousPresence of infectiousp-valuediseasediseaseAverage age (years)65 (± 9,32)65 (± 8,9)0,059Female15 (34,8%)2 (4,6%)0,51Glycohemoglobin (%)7,25 (±0,94)7,9 (±1,4)0,039Length of DM2 (years)8 (±8,98)10 (±9)0,057Length of hospital stay until surgery (days)6,7 (1,5-8)12,8 (4 -25)0,223Drain time in UCI (days)111Length of stay in UCI (days)2 (±1,5)2 (±1,7)0,062Creatinine clearance (mL/min)67 (±26)59 (±21,3)0,039Use of insulin prior to hospitalization11 (30,6%)4 (57,1%)0,177Smoking2 (5,7%)1 (16,7%)0,341Pulmonary disease28 (82,9%)5 (71,4%)0,482 * Glycemic control reduce infections in post-liver transplant patients: Results of a prospective, randomized study AWallia J. Clin. Endocrinol. Metab 102 2017 * Coronary Artery Disease, and Type 2 Diabetes Mellitus. Int RNaito KMiyauchi Heart J 58 2017 * Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes JRutering Nat. Rev Drug Discov 5 2016 * Diabetes as pro-infective risk factor in total HIP replacement PVannini Acta Diabetol. Lat 21 1984 * Influence of Diabetes Mellitus on Early and Late Outcome after Percutaneous Transluminal Coronary Angioplasty DCMorris 2012 91 * Perioperative Hyperglycemia Is a Strong Correlate of Postoperative Infection in Type II Diabetic Patients after Coronary Artery Bypass Grafting MGuvener IPasaoglu MDemircin MOc Endocrine 49 2003 * Glucose and outcome after cardiac surgery: What are the issues? HPGrocott J. Extra. Corpor. Technol 38 2006 * A study of a preoperative intervention in patients with diabetes undergoing cardiac surgery GALee SWyatt DTopliss KZWalker RStoney 2014 21 * Postoperative Glycemic Control in Cardiac Surgery Patients TBreithaupt Baylor Univ. Med. Cent. Proc 23 2017 * Coronary artery disease and diabetes mellitus DAronson EREdelman Cardiol 32 2014 * Prognosis and Complications of Diabetic Patients Undergoing Isolated Coronary Artery Bypass Surgery KA QSantos BBerto AGSousa FA ACosta Da Brazilian J. Cardiovasc. Surg 31 2016 * Perioperative Glucose Control and Infection Risk in Older Surgical Patients PLee LMin LMody Curr. Geriatr 3 2014 * HbA1c and diabetes predict perioperative hyperglycemia and glycemic variability in on-pump coronary artery bypass graft patients MMasla AGottschalk MEDurieux DSGroves J. Cardiothorac. Vasc. Anesth 25 2011 * Effect of elevated hemoglobin A1c in diabetic patients on complication rates after Roux-en-Y gastric bypass LRawlins MPRawlins CCBrown DLSchumacher Surg. Obes. Relat. Dis 9 2013 * The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: An 8-year prospective cohort study SEWoods JMSmith SSohail ASarah AEngle 2004 126 * Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery MEHalkos J. Thorac. Cardiovasc. Surg 136 2008 * Glucose Control Lowers the Risk of Wound Infection in Diabetics after Open Heart Operations MbaZerr KJ Ann. Thorac. Surg 63 2002 * Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting SEKassaian Cardiovasc. Diabetol 11 1 2012 * Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection MIzadi ARYA Atheroscler 10 2014 * Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery JLCarson J. Am. Coll. Cardiol 40 2002 * Diabetic control and coronary artery bypass: Effect on short-term outcomes SStrahan Asian Cardiovasc. Thorac. Ann 21 2013 * Incidence and Predictors of Hospitalization for Bacterial Infection in Community-Based Patients with Type 2 Diabetes: The Fremantle Diabetes Study EJHamilton PLoS 8 2013 * Staphylococcus aureus Infections in German Patients with Type 2 Diabetes Mellitus after Orthopedic Surgery: Incidence, Risk Factors, and Clinical and Health-Economic Outcomes FGottschalk Surg. Infect. (Larchmt) 18 2017 * Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients ANAl-Niaimi Gynecol. Oncol 136 2015 * Use of a lower cut-off value for HbA1c to predict postoperative renal complication risk in patients undergoing coronary artery bypass grafting FGumus J. Cardiothorac. Vasc * Anesth 2013 27 * The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery HSato J. Clin. Endocrinol. Metab 95 2010 * Analysis of multiple risk factors affecting the result of free flap transfer for necrotising soft tissue defects of the lower extremities in patients with type 2 diabetes mellitus BKKim J. Plast. Reconstr. Aesthetic Surg 67 2014